Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
GM2A pseudogene 2 (GM2AP2) is a non-functional gene sequence on the human genome, designated as a pseudogene of the GM2A locus. Unlike the functional GM2A gene, which encodes the ganglioside GM2 activator protein involved in lysosomal degradation of GM2 ganglioside, the GM2A pseudogene 2 has no known protein product or biological function and is not considered a therapeutic or pharmacological target. It is catalogued in genome databases (e.g., NCBI Gene 100287900, Ensembl ENSG00000239428) on chromosome 1 and exists as a remnant of gene duplication, with no known clinical, diagnostic, or therapeutic relevance[7]. Key points: - This is a pseudogene, meaning it is a non-coding, non-functional genetic element. - There is no evidence GM2AP2 produces a protein or acts as a drug target. - It should not be confused with the functional GM2A gene/protein, which has significant biological and disease relevance[1][3][5][7]. - "GM2A pseudogene 2" is not a receptor, enzyme, transporter, or other canonical therapeutic or biological target. If you need information on the functional gene/protein (GM2A, ganglioside GM2 activator), let me know.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on GM2A pseudogene 2 (GM2AP2).